The medical regulator is assessing whether Pfizer’s COVID vaccine should be approved for 12 to 16-year-olds.

Infectious Disease Expert Professor Robert Booy told Ben Fordham many countries have already approved the vaccines for use in 12 to 15-year-olds.

“Children won’t be a priority yet, but it is safe.”

Press PLAY below to hear the full interview